Skip to main content
SpringerLink
Log in

Leitlinien zur Implantation von Defibrillatoren

  • LEITLINIEN
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al-Khatib SM, Lucas FE, Jollis JG, Malenka DJ, Wennberg DE (2005) The relation between patients’ outcomes and the volume of cardioverter- defibrillator implantation procedures performed by physicians treating medicare beneficiaries. J Am Coll Cardiol 46:1536–1540

    Article  PubMed  Google Scholar 

  2. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN (1999) Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 34:2023–2030

    Article  PubMed  CAS  Google Scholar 

  3. Antzelevitch C, Brugada P, Borggrefe M et al (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111:659–670 (Erratum in: Circulation 2005;112(4):e74)

    Article  PubMed  Google Scholar 

  4. Bänsch D, Brunn J, Castrucci M et al (1998) Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 31:608–615

    Article  PubMed  Google Scholar 

  5. Bänsch D, Antz M, Boczor S et al (2002) Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 105:1453–1458

    Article  PubMed  Google Scholar 

  6. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  7. Böcker D, Block M, Isbruch F et al (1995) Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 73:158–163

    PubMed  Google Scholar 

  8. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold NY, Friedman PA (2001) Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol 24:1623–1630

    Article  PubMed  CAS  Google Scholar 

  9. Bristow MR, Saxon LS, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140– 2150

    Article  PubMed  CAS  Google Scholar 

  10. Coggins DL, Lee RJ, Sweeney J et al (1994) Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 23:1333–1341

    Article  PubMed  CAS  Google Scholar 

  11. Connolly SJ, Gent M, Roberts RS et al (1993) Canadian Implantable Defibrillator Study (CIDS): Study design and organization. Am J Cardiol 72:103F–108F

    Article  PubMed  CAS  Google Scholar 

  12. Connolly SJ, Gent M, Roberts RS et al (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302

    PubMed  CAS  Google Scholar 

  13. Connolly SJ, Hallstrom AP, Cappato R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071–2078

    Article  PubMed  CAS  Google Scholar 

  14. Cook JR, Rizo-Patron C, Curtis AB et al (2002) Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Am Heart J 143:821–826

    Article  PubMed  Google Scholar 

  15. Corrado D, Leoni L, Link MS et al (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation 108:3084–3091

    Article  PubMed  Google Scholar 

  16. Domanski MJ, Sakseena S, Epstein AE et al (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 34:1090–1095

    Article  PubMed  CAS  Google Scholar 

  17. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J (1996) Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 78:703–706

    Article  PubMed  CAS  Google Scholar 

  18. Hohnloser SH, Andresen D, Block M et al (2000) Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 89:126–135

    Article  Google Scholar 

  19. Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481–2488

    Article  PubMed  CAS  Google Scholar 

  20. Jung W, Lüderitz B (1996) Quality of life and driving in recipients of the implantable cardioverter-defibrillator. Am J Cardiol 78:51–56

    Article  PubMed  CAS  Google Scholar 

  21. Jung W, Anderson M, Camm AJ et al (1997) Recommendations for driving of patients with implantable cardioverter defibrillators. Eur Heart J 18:1210–1219

    PubMed  CAS  Google Scholar 

  22. Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158

    Article  PubMed  CAS  Google Scholar 

  23. Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33:1964–1970

    Article  PubMed  CAS  Google Scholar 

  24. Kuck KH, Cappato R, Siebels J, Ruppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748– 754

    PubMed  CAS  Google Scholar 

  25. Mangi AA, Boeve TJ, Vlahakes GJ et al (2002) Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest. Ann Thorac Surg 74:1510–1516

    Article  PubMed  Google Scholar 

  26. Maron BJ, Shen WK, Link MS et al (2000) Efficacy of implantable cardioverter- defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373

    Article  PubMed  CAS  Google Scholar 

  27. Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24: 1965–1991

    Article  PubMed  Google Scholar 

  28. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB (1999) Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 34:1082–1089

    Article  PubMed  CAS  Google Scholar 

  29. Mittal S, Hao SC, Iwai S, Markowitz SM, Slotwiner DJ, Lerman BB (2001) Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 38:371–376

    Article  PubMed  CAS  Google Scholar 

  30. Moss AJ, Zarebra W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  31. Nademanee K, Veerakul G, Mower M et al (2003) Defibrillator Versus beta- Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation 107:2221–2226

    Article  PubMed  Google Scholar 

  32. Olson PJ, Woelfel A, Simpson RJ Jr, Foster JR (1993) Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 71:823–826

    Article  PubMed  CAS  Google Scholar 

  33. Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874

    Article  PubMed  Google Scholar 

  34. Raitt MH, Renfroe EG, Epstein AE et al (2001) “Stable” ventricular tachycardia is not a benign rhythm: insights from the antiarrhythmics versus implantable defibrillators (AVID) registry. Circulation 103:244–252

    PubMed  CAS  Google Scholar 

  35. Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP (2004) Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow- up and its implications. Circulation 109:1848–1853

    Article  PubMed  Google Scholar 

  36. Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2:416–417

    Article  PubMed  Google Scholar 

  37. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M (2000) Identification of patients most likely to benefit from implantable cardioverter- defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 101:1660–1664

    PubMed  CAS  Google Scholar 

  38. Siebels J, Kuck KH (1994) Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 127:1139–1144

    Article  PubMed  CAS  Google Scholar 

  39. Steinberg JS, Beckman K, Greene HL et al (2001) Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol 12:996–1001

    Article  PubMed  CAS  Google Scholar 

  40. Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 41:1707–1712

    Article  PubMed  Google Scholar 

  41. The AVID Investigators (1995) Antiarrhythmics Versus Implantable Defibrillators (AVID) – rationale, design, and methods. Am J Cardiol 75:470– 475

    Article  Google Scholar 

  42. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic- drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576– 1583

    Article  Google Scholar 

  43. Wichter T, Paul M, Wollmann C et al (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109:1503–1508

    Article  PubMed  Google Scholar 

  44. Wilber DJ, Zareba W, Hall WJ et al (2004) Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109:1082–1084

    Article  PubMed  Google Scholar 

  45. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M (2003) Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14:337–341

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Klinik für Innere Medizin III Kardiologie, Pneumologie, Angiologie, Vöhrenbacherstr. 23, 78050, Villingen-Schwenningen

    Werner Jung

  2. Vivantes Kliniken Am Urban/Im Friedrichshain, Klinik für Innere Medizin, Kardiologie/Angiologie, Dieffenbachstr. 1, 10967, Berlin

    Dietrich Andresen

  3. Klinik Augustinum München Kardiologie, Wolkerweg 16, 81375, München

    Michael Block

  4. Universitätsklinikum Münster, Medizinische Klinik und Poliklinik C – Kardiologie und Angiologie, Albert-Schweitzer-Str. 33, 48149, Münster

    Dirk Böcker

  5. J.W. Goethe Universität Frankfurt, Medizinische Klinik III (Kardiologie/Nephrologie), Theodor-Stern-Kai 7, 60590, Frankfurt

    Stefan H. Hohnloser

  6. AK St. Georg II. Med. Abteilung (Kardiologie), Lohmühlenstr. 5, 20099, Hamburg

    Karl-Heinz Kuck

  7. Kerckhoff-Klinik GmbH Kardiologie/Elektrophysiologie, Benekestr. 2–8, 61231, Bad Nauheim

    Johannes Sperzel

Authors
  1. Werner Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dietrich Andresen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Block
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dirk Böcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefan H. Hohnloser
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karl-Heinz Kuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Johannes Sperzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Jung.

Additional information

Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie G. Ertl, D. Andresen, M. Böhm, M. Borggrefe, J. Brachmann, F. de Haan, A. Osterspey, S. Silber, H. J. Trappe, außerdem G. Arnold, H. M. Hoffmeister, E. Fleck

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, W., Andresen, D., Block, M. et al. Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95, 696–708 (2006). https://doi.org/10.1007/s00392-006-0475-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-006-0475-7

Keywords

Search

Navigation